Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-9.02x4.2x-0.23x4.02x-7.42x-6.96x-.--% 2.24B
17.29x2x-2.51x3.79x10.17x11.26x0.58% 67.96B
27.02x4.05x2.1x5.55x16.28x20.3x0.59% 54.4B
32.87x6.59x0.64x11.12x21.25x24.77x-.--% 40.63B
-46.91x2.56x0.36x3.29x9.71x11.33x3.27% 41.74B
30.31x1.57x-1.2x3.47x10.96x12.8x-.--% 29.37B
-8.83x5.36x-0.46x12.88x-7.91x-7.47x-.--% 30.38B
17.2x3.44x2.29x3.3x10.01x9.82x-.--% 23.68B
57.92x5.51x0.33x6.05x41.38x40.23x-.--% 19.15B
26.74x3.74x0.02x5.48x14.72x20.33x-.--% 17.14B
-41.11x-7.19x0.98x19.11x-58.05x-60.82x-.--% 17.68B
-125.28x13185.91x2.72x12.87x-114.19x-127.16x-.--% 12.81B
17.03x - 0.18x3.62x13.26x15.89x-.--% 11.59B
54.89x22.38x0.52x33.22x46.98x48.45x0.17% 10.64B
48.15x - 3.79x - - - -.--% 10.94B
71.22x5.04x-0.92x - - - - 6.74B
11.83x1.03x0.41x1.8x7.28x9.75x2.84% 6.21B
13.54x1.24x-0.2x2.33x6.02x7.29x1.67% 5.42B
-46.28x - -0.83x - - - - 5.83B
27x - 1.33x7.22x19.16x22.88x0.38% 5.5B
Average 8.78x 827.96x 0.47x 8.18x 2.33x 3.10x 0.53% 21B
Weighted average by Cap. 9.72x 440.93x 0.23x 7.31x 6.41x 7.70x 0.59%
Biopharmaceuticals